Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 799, Issue 1, 2004, Pages 23-36

  Schleyer, E ^a   Pursche, S ^a   Kohne C H ^a   Schuler, U ^a   Renner, U ^a   Gschaidmeier, H ^d   Freiberg Richter, J ^a   Leopold, T ^a   Jenke, A ^a   Bonin, M ^a   Bergemann, T ^a   Le Coutre, P ^b   Gruner, M ^a   Bornhauser M ^a   Ottmann, O G ^c   Ehninger, G ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d Novartis Pharma AG   (Germany)

Author keywords

N Desmethyl STI; STI 571

Indexed keywords

BIOASSAY; BODY FLUIDS; CELLS; ELECTROCHEMISTRY; LIQUID CHROMATOGRAPHY; METABOLITES; PHARMACOKINETICS;

CEREBROSPINAL FLUID (CSF); ELECTROCHEMICAL DETECTION;

BIOMEDICAL ENGINEERING;

DRUG METABOLITE; IMATINIB;

ACCURACY; ARTICLE; BLOOD; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DETERMINATION; ELECTROCHEMISTRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIQUID CHROMATOGRAPHY; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QUANTITATIVE ANALYSIS; URINALYSIS;

EID: 10744233520     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.10.025     Document Type: Article

References (28)

1. Buchdunger E., Zimmermann J., Mett H., Meyer T., Muller M., Druker B.J., Lydon N.B. Cancer Res. 56:1996;100.
2. Buchdunger E., Cioffi C.L., Law N., Stover D., Ohno-Jones S., Druker B.J., Lydon N.B. J. Pharmacol. Exp. Ther. 295:2000;139.
3. Druker B.J., Tamura S., Buchdunger E., Ohno S., Segal G.M., Fanning S., Zimmermann J., Lydon N.B. Nat. Med. 2:1996;561.
4. Druker B.J., Sawyers C.L., Kantarjian H., Resta D.J., Reese S.F., Ford J.M., Capdeville R., Talpaz M. N. Engl. J. Med. 344:2001;1038.
5. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. N. Engl. J. Med. 344:2001;1031.
6. Sawyers C.L., Hochhaus A., Feldman E., Goldman J.M., Miller C.B., Ottmann O.G., Schiffer C.A., Talpaz M., Guilhot F., Deininger M.W., Fischer T., O'Brien S.G., Stone R.M., Gambacorti-Passerini C.B., Russell N.H., Reiffers J.J., Shea T.C., Chapuis B., Coutre S., Tura S., Morra E., Larson R.A., Saven A., Peschel C., Gratwohl A., Mandelli F., Ben-Am M., Gathmann I., Capdeville R., Paquette R.L., Druker B.J. Blood. 99:2002;3530.
7. Ottmann O.G., Druker B.J., Sawyers C.L., Goldman J.M., Reiffers J., Silver R.T., Tura T., Fischer S., Deininger M.W., Schiffer C.A., Baccarani M., Gratwohl A., Hochhaus A., Hoelzer D., Fernandes-Reese S., Gathmann I., Capdeville R., O'Brien S.G. Blood. 100:2002;1965.
8. Kantarjian H., Sawyers C., Hochhaus A., Guilhot F., Schiffer C., Gambacorti-Passerini C., Niederwieser D., Resta D., Capdeville R., Zoellner U., Talpaz M., Druker B., Goldman J., O'Brien S.G., Russell N., Fischer T., Ottmann O., Cony-Makhoul P., Facon T., Stone R., Miller C., Tallman M., Brown R., Schuster M., Loughran T., Gratwohl A., Mandelli F., Saglio G., Lazzarino M., Russo D., Baccarani M., Morra E. N. Engl. J. Med. 346:2002;645.
9. le Coutre P., Kreuzer K.A., Na I.K., Lupberger J., Holdoff M., Appelt C., Schwarz M., Muller C., Gambacorti-Passerini C., Platzbecker U., Bonnet R., Ehninger G., Schmid C.A. Blood Cells Mol. Dis. 28:2002;75.
10. Blume-Jensen P., Hunter T. Nature. 411:2001;355.
11. Hubbard S.R., Till J.H. Annu. Rev. Biochem. 69:2000;373.
12. Gambacorti-Passerini C., le Coutre P., Mologni L., Fanelli M., Bertazzoli C., Marchesi E., di Nicola M., Biondi A., Corneo G.M., Belotti D., Pogliani E., Lydon N.B. Blood Cells Mol. Dis. 23:1997;380.
13. le Coutre P., Mologni L., Cleris L., Marchesi E., Buchdunger E., Giardini R., Formelli F., Gambacorti-Passerini C. J. Natl. Cancer Inst. 91:1999;163.
14. Deininger M.W., Goldman J.M., Lydon N., Melo J.V. Blood. 90:1997;3691.
15. Sawyers C.L. J. Clin. Oncol. 18:2001;13.
16. Deininger M.W., O'Brien S.G., Ford J.M., Druker B.J. J. Clin. Oncol. 8:2003;1.
17. Gambacorti-Passerini C., Zucchetti M., Russo D., Frapolli R., Verga M., Bungaro S., Tornaghi L., Rossi F., Pioltelli P., Pogliani E., Alberti D., Corneo G., D'Incalci M. Clin. Cancer Res. 9:2003;625.
18. Gambacorti-Passerini C., Barni R., le Coutre P., Zucchetti M., Cabrita G., Cleris L., Rossi F., Gianazza E., Brueggen J., Cozens R., Pioltelli P., Pogliani E., Corneo G., Formelli F., D'Incalci M. J. Natl. Cancer Inst. 92:2000;1641.
19. Gorre M.E., Mohammed M., Ellwood K., Hsu N., Paquette R., Rao P.N., Sawyers C.L. Science. 293:2001;876.
20. le Coutre P., Tassi E., Varella-Garcia M., Barni R., Mologni L., Cabrita G., Marchesi E., Supino R., Gambacorti-Passerini C. Blood. 95:2000;1758.
21. Schleyer E., Ottmann O.G., Leopold T., Bonin M., Freiberg-Richter J., Jenke A., Berndt A., Bornhäuser M., Ehninger G., Kreuzer K.A., le Coutre P. Medreview. 12:2002;14.
22. J.M. Ford, Imatinib Mesilate, Investigators' Brochure, fifth ed., June 2002, Property of Novartis Pharma AG.
23. GLEEVEC™ (Imatinib Mesylate) Capsules, NDA 21-335, Package Insert, 2001.
24. Bakhtiar R., Lohne J., Ramos L., Khemani M., Hayes M., Tse F. J. Chromatogr. B. 768:2002;325.
25. Petzer A.L., Gunsilius E., Hayes M., Stockhammer G., Duba H.C.H., Schneller F., Gruenewald K., Poewe W., Gastl G. Br. J. Haematol. 117:2002;623.
26. Heinzel G., Hammer R., Wolf M., Koss F.W., Bozler G. Arzneimittelforschung. 27:1977;904.
27. Hammer R., Bozler G., Heinzel G., Koss W. Arzneimittelforschung. 27:1977;928.
28. T. Illmer, M. Schaich, U. Platzbecker, J. Freiberg-Richter, M. Bonin, S. Pursche, T. Bergemann, G. Ehninger, E. Schleyer, submitted for publication.